Skip to main content
Premium Trial:

Request an Annual Quote

Sias to Acquire Lab Equipment Firm Xiril

NEW YORK (GenomeWeb News) – Swiss liquid handling systems firm Sias has inked an agreement to acquire laboratory equipment and software firm Xiril.

The deal is expected to be completed at the end of this month and will provide Sias with products focused on the diagnostic and DNA analysis markets, the Hombrechtikon, Switzerland-based firm said in a statement released yesterday. Financial terms of the deal were not disclosed, but Sias said that it would pay for the acquisition with company stock.

Sias added that the acquisition enables it to maintain rapid growth, while increasing its market share and sharpening its "competitive edge in a market that still has enormous potential."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more